Trial intelligence / Profile preview

Ultrasound-guided botulinum A injections for pain in rotator cuff tear arthropathy

2015-002176-25Phase 2Completed

Sponsor
Royal Devon University Healthcare NHS Foundation Trust
Start
Feb 2016
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, single-arm trial of botulinum toxin type A in rotator cuff arthropathy (CTA), sponsored by Royal Devon University Healthcare NHS Foundation Trust. Primary endpoint: VAS pain score change over time. Started Feb 2016; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

rotator cuff arthropathy (CTA)

Beyond the preview

Go deeper on 2015-002176-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-002176-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call